Aharon Schwartz - Jan 3, 2023 Form 4 Insider Report for Protalix BioTherapeutics, Inc. (PLX)

Role
Director
Signature
/s/ Joseph R. Magnas, POA
Stock symbol
PLX
Transactions as of
Jan 3, 2023
Transactions value $
$155,815
Form type
4
Date filed
1/5/2023, 04:08 PM
Previous filing
Sep 9, 2022
Next filing
Oct 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PLX Common Stock Purchase $156K +110K +171.88% $1.42 174K Jan 3, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $1.430 to $1.405 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.